These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38733695)

  • 1. Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies.
    Capiau A; Mehuys E; Grymonprez M; Van Tongelen I; Christiaens T; Tommelein E; Philippe G; Lahousse L; De Backer T; Boussery K
    Thromb Res; 2024 Jun; 238():223-231. PubMed ID: 38733695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care.
    Capiau A; Mehuys E; De Bolle L; Van Tongelen I; De Backer T; Boussery K
    Int J Clin Pharm; 2023 Apr; 45(2):364-374. PubMed ID: 36446994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of direct oral anticoagulant drug interactions in hospitalized patients.
    Al Zaria MH; Buckley LF; Dell'orfano H; Manzo P; Fanikos J
    J Thromb Thrombolysis; 2024 Apr; 57(4):598-602. PubMed ID: 38554223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients.
    Forbes HL; Polasek TM
    Ther Adv Drug Saf; 2017 Oct; 8(10):319-328. PubMed ID: 29593860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants.
    Lee JY; Oh IY; Lee JH; Kim SY; Kwon SS; Yang HJ; Kim YK; Bang SM
    Thromb Res; 2020 Nov; 195():243-249. PubMed ID: 32823239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants in real clinical practice: analysis of patient characteristics and prescribing patterns in a large teaching hospital.
    Kováčová B; Červeňová J
    Pharmazie; 2017 Sep; 72(9):555-560. PubMed ID: 29441984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Drug Interactions with Direct Oral Anticoagulants.
    Foerster KI; Hermann S; Mikus G; Haefeli WE
    Clin Pharmacokinet; 2020 Aug; 59(8):967-980. PubMed ID: 32157630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer.
    Otten LS; Piet B; van den Heuvel MM; Marzolini C; van Geel RMJM; Gulikers JL; Burger DM; Leentjens J; Ter Heine R
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35705208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events.
    Zhou M; Leonard CE; Brensinger CM; Bilker WB; Kimmel SE; Hecht TEH; Hennessy S
    Clin Pharmacol Ther; 2020 Aug; 108(2):377-386. PubMed ID: 32275326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapy.
    Tran E; Ledbetter LE
    J Thromb Thrombolysis; 2023 May; 55(4):721-728. PubMed ID: 36781620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice.
    Ferri N; Colombo E; Tenconi M; Baldessin L; Corsini A
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Potential Drug-Drug Interactions With Direct Oral Anticoagulants in a Large Urban Hospital.
    Mo Y; Karakas-Torgut A; Pham AQ
    J Pharm Pract; 2020 Apr; 33(2):136-141. PubMed ID: 30004271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.
    Geerts AF; De Koning FH; De Smet PA; Van Solinge WW; Egberts TC
    Drug Saf; 2009; 32(12):1189-97. PubMed ID: 19916585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach.
    Truong B; Hornsby L; Fox BI; Chou C; Zheng J; Qian J
    J Thromb Thrombolysis; 2023 Nov; 56(4):555-567. PubMed ID: 37563503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review.
    Li A; Li MK; Crowther M; Vazquez SR
    Thromb Res; 2020 Oct; 194():240-245. PubMed ID: 33213849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week.
    Wiggins BS; Dixon DL; Neyens RR; Page RL; Gluckman TJ
    J Am Coll Cardiol; 2020 Mar; 75(11):1341-1350. PubMed ID: 32192661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants.
    Carollo M; Crisafulli S; Ciccimarra F; Andò G; Diemberger I; Trifirò G
    Expert Opin Drug Metab Toxicol; 2024 Mar; 20(3):157-164. PubMed ID: 38386102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of anticoagulation in patients with human immunodeficiency virus/acquired immunodeficiency virus.
    Sabourin AA; Patel T; Saad S; Renner E; Mouland E; Adie S; Ha NB
    Thromb Res; 2021 Apr; 200():102-108. PubMed ID: 33571723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies.
    Wang TF; Hill M; Mallick R; Chaudry H; Unachukwu U; Delluc A; Carrier M
    Thromb Res; 2023 Nov; 231():128-134. PubMed ID: 37857226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.